Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
This study is ongoing, but not recruiting participants.
Study NCT00039091 Information provided by National Cancer Institute (NCI)
First Received: June 6, 2002 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Lung Cancer
Melanoma (Skin)
Myelodysplastic Syndromes
Ovarian Cancer
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Lung Neoplasms
Melanoma
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Ovarian Neoplasms
Preleukemia
Syndrome
More general conditions related to this trial
Adnexal Diseases
Bone Marrow Diseases
Carcinoma
Disease
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Hematologic Diseases
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Ovarian Diseases
Pathologic Processes
Precancerous Conditions
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Urogenital Neoplasms
Interventions listed in this trial
ipilimumab
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Cytotoxic T-lymphocyte antigen 4
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Back to top of Main Content
